Self-Replicating mRNA Approved by European Committee Despite Trial Deaths and 90% Adverse Reaction Rate
Self-replicating mRNA vaccines have received the greenlight from the European Committee for widespread use in Europe, despite alarming clinical trial results that included participant deaths and a staggering 90% reporting side effects. The European Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion recommending marketing authorization for Kostaive, a self-replicating mRNA injection—often referred to as … Leer más